ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,488.15
0.35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Onward Medical NV (ONWD) Cotización

Onward Medical NV

Onward Medical NV (ONWD)

Onward Opportunities Limited
5.48
0.14
(2.62%)
Cerrado 27 Diciembre 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
5.48
Postura de Compra
5.40
Postura de Venta
5.48
Volume Operado de la Acción
154,500
5.32 Rango del Día 5.50
1.85 Rango de 52 semanas 6.58
Capitalización de Mercado [m]
189.766M
Precio Anterior
5.34
Precio de Apertura
5.38
Hora
72
@
5.48
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
109,567
Acciones en circulación
34,628,832
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.74
Beneficio por acción (BPA)
-1.04
turnover
532k
Beneficio neto
-36.18M

Acerca de Onward Medical NV

Sector
Medical Laboratories
Industria
Medical Laboratories
Sitio web
www.onwd.com
Sede
Eindhoven, North Brabant, Nld
Fundado
-
Onward Medical NV is listed in the Medical Laboratories sector of the Euronext with ticker ONWD. The last closing price for Onward Medical NV was 5.34 €. Over the last year, Onward Medical NV shares have traded in a share price range of 1.85 € to 6.58 €.

Onward Medical NV currently has 34,628,832 shares in issue. The market capitalisation of Onward Medical NV is 184.92 € million. Onward Medical NV has a price to earnings ratio (PE ratio) of -5.74.

ONWD Últimas noticias

Más noticias

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury THIS PRESS...

19 Diciembre 2024
UK Regulatory

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière...

19 Diciembre 2024
UK Regulatory

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology...

19 Diciembre 2024
GlobeNewswire Inc.

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec. 12, 2024...

12 Diciembre 2024
GlobeNewswire Inc.

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to...

12 Diciembre 2024
UK Regulatory

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor Signed exclusive license with CEA to develop and commercialize WIMAGINE...

26 Noviembre 2024
GlobeNewswire Inc.

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company’s top investor Signed exclusive...

26 Noviembre 2024
UK Regulatory

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke Grant supports the first clinical trials studying the potential for brain-computer interface...

19 Noviembre 2024
UK Regulatory

ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke

Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke...

19 Noviembre 2024
GlobeNewswire Inc.

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights

ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights Company to provide update on significant milestones and near-term plans, including its recent successful...

12 Noviembre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.469.163346613555.025.64.774064045.13369904DE
40.817.0940170944.685.64.541199424.96951562DE
120.183.396226415095.36.34.511095675.06641229DE
260.6312.98969072164.856.34.51605275.05135854DE
522.3876.77419354843.16.581.85761825.00770286DE
156-3.92-41.70212765969.412.281.85310075.1174915DE
260-7.54-57.91090629813.0213.281.85306015.44861619DE

ONWD - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Onward Medical NV?
El precio actual de las acciones de Onward Medical NV es 5.48 €
¿Cuántas acciones de Onward Medical NV están en circulación?
Onward Medical NV tiene 34,628,832 acciones en circulación
¿Cuál es la capitalización de mercado de Onward Medical NV?
La capitalización de mercado de Onward Medical NV es EUR 184.92M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Onward Medical NV?
Onward Medical NV ha negociado en un rango de 1.85 € a 6.58 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Onward Medical NV?
El ratio precio/beneficio de Onward Medical NV es -5.74
¿Cuál es el ratio de efectivo a ventas de Onward Medical NV?
El ratio de efectivo a ventas de Onward Medical NV es 389.61
¿Cuál es la moneda de reporte de Onward Medical NV?
Onward Medical NV presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Onward Medical NV?
El último ingresos anual de Onward Medical NV es EUR 532k
¿Cuál es el último beneficio anual de Onward Medical NV?
El último beneficio anual de Onward Medical NV es EUR -36.18M
¿Cuál es la dirección registrada de Onward Medical NV?
La dirección registrada de Onward Medical NV es HIGH TECH CAMPUS 32, EINDHOVEN, NORTH BRABANT, 5656 AE
¿Cuál es la dirección del sitio web de Onward Medical NV?
La dirección del sitio web de Onward Medical NV es www.onwd.com
¿En qué sector industrial opera Onward Medical NV?
Onward Medical NV opera en el sector MEDICAL LABORATORIES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

Discusión

Ver feed completo
mick mick 3 minutos hace
1975 proof set

https://youtu.be/WO1x13UCrQk

https:// youtu.be/WO1x13UCrQk
mrfence mrfence 3 minutos hace
Ending GSE conservatorships a ‘show-me story,’ says BTIG
BTIG says a “considerable amount of our time is spent thinking and talking about” Fannie Mae (FNMA) and Freddie Mac (FMCC) because those “mortgage behemoths are integral to the housing market,” though with President Trump returning to
FMCC
Eli's Gone Eli's Gone 3 minutos hace
I doubt the Cards would take Stroman off our hands---along with Peraza who is becoming the next Florial--Peraza was can't miss and untouchable for 2 years in any trade talks and is now chopped liver with an IF position open
Kjv Kjv 4 minutos hace
Looks like we have forgotten the drill?
KoolMc and Limetime....completely ignore this mindless posts! 

I saw 12 messages on notifications and was excited and only to get disappointed....lol.

Just ignore him...happy to have gotten a few millions at 1s last 2 weeks
HQGE
ty3 ty3 4 minutos hace
In at 4s & 5s, I'll wait for 3s but I think some news will come first ?
CGAC
glenn1919 glenn1919 5 minutos hace
wimi................................https://stockcharts.com/h-sc/ui?s=wimi&p=W&b=5&g=0&id=p86431144783
WIMI
Kick Up Kick Up 5 minutos hace
Which is why investing is an individual responsibility. Bashers already know they have to bash, and nervous investors are easy targets for them.
If I made my decisions on what the basher’s post, they would be the only winners. Trust your own research…your odds improve greatly!
WDLF
Zorax Zorax 7 minutos hace
Got a link to any pictures or 3rd party coverage that this glorified power generator exists? These guys love the inventive prose.
tia.

This is so much garbage nonsense. And of course every thing is envisioned and going to be...

That's where Entrex comes in.
RGLG
glenn1919 glenn1919 9 minutos hace
qmmm........wimi.........sldp........rvsn............................https://stockcharts.com/h-sc/ui?s=rvsn&p=D&yr=0&mn=2&dy=12&id=p84071410134
Konaploinks Konaploinks 10 minutos hace
Yep. I second that. I’m sending the main office in Maryland some Kona Coffee and some Macadamia Nuts from Kona . Good job. Well done. That 40 burger is tasting mighty good and I know the 50 burger is already on the grill and just about well done. Go Ionq! 🎉🎉🎉🎉Ἰ
IONQ
frankyahoo frankyahoo 11 minutos hace
1st I heard of this. Thx
ADAUSD
k9uwa k9uwa 12 minutos hace
For Sure they will release the OLE. It should be one hellava a SHOW. And your Quote
"Restoring brain shrink/brain volume loss to that of a healthy individual is going to put 2-73 over the top at the EMA."
That is the icing on the cake. I expect that within the OLE will be considerable
AVXL
johnydollar johnydollar 13 minutos hace
You probably bought some naked illegal shares.......

They want them back........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
StockItOut StockItOut 13 minutos hace
Whether it's fake or failed. As failed, fake or not aside, Xeriant, Inc as Xeriant Aerospace in the construction boards business is ludicrous, pretty much comical.

I'm telling you though.., that Appellate case is something.

That is Xeriant. I'm excited to see how it
XERI
CanItBThisEZ2Make CanItBThisEZ2Make 15 minutos hace
$MAXN
Buy: 189,914
Neutral: 70,043
Sell: 235,728
Volume: 495,685
MAXN
johnydollar johnydollar 15 minutos hace
Yeah, he is too young for the revocation party 🥳........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹
DBMM
nowwhat2 nowwhat2 18 minutos hace
You have exhibited absolutely ZERO awareness, with regards to all that which has been manifesting.......


All you've been able to "muster on up", have been dozens of cheap, slimey freaking damned insults ......WIERD !

For example ;
I'm guessing when you w
XRPUSD
Pilgrim1 Pilgrim1 20 minutos hace
Chiugray, thank you and George Bailey too, for responding. I found this (in this document (called) "Prospectus" that I suppose ties to the $5 million in the Press Release:
"Pursuant to this prospectus supplement, the Company is offering potentially 21,587,302 shares of our Common Stock. 20,
NWBO
devil dog 96 devil dog 96 21 minutos hace
Your just guessing and making no proof scam theory promo claims. 😃 LMAO

"Probably just another idiot. What else would you expect with a scam like this"

This is nothing more then no proof scam theory clown🤡 show promo filler.

The no proo
ATMH
biotechinvestor1 biotechinvestor1 21 minutos hace
Remember that subcutaneous Opdivo performed better (33% greater efficacy) vs IV Opdivo (see link below). This will lead to not only a combination patent effective until late 2030's BUT ALSO a higher conversion rate to subutaneous. Bristol will likely push the subcutaneous version hard to avoid the p
HALO
blackhawks blackhawks 23 minutos hace
There should be GOP Prank Gift boxes, empty of course, on How to Elect a House Speaker, How to Shut Down the Government, Fight a Pandemic, Create a Respectable # of New jobs, Your Very Own Infrastructure Bill, Your Very Own Jewish Space Laser and How Not to Get Thrown out of a Theater for Giving a H
Researchfyi Researchfyi 23 minutos hace
Sounds like I have 9 aliases now. :)
LQMT
shajandr shajandr 24 minutos hace
No you're nott.

Su Consulta Reciente

EU
ONWD
Onward Medical NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados